These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 36825509)

  • 1. Optimal allocation to treatment sequences in individually randomized stepped-wedge designs with attrition.
    Moerbeek M
    Clin Trials; 2023 Jun; 20(3):242-251. PubMed ID: 36825509
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The cluster randomized crossover trial: The effects of attrition in the AB/BA design and how to account for it in sample size calculations.
    Moerbeek M
    Clin Trials; 2020 Aug; 17(4):420-429. PubMed ID: 32191129
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Optimal allocation of clusters in stepped wedge designs with a decaying correlation structure.
    Moerbeek M
    PLoS One; 2023; 18(8):e0289275. PubMed ID: 37585398
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The optimal design of stepped wedge trials with equal allocation to sequences and a comparison to other trial designs.
    Thompson JA; Fielding K; Hargreaves J; Copas A
    Clin Trials; 2017 Dec; 14(6):639-647. PubMed ID: 28797179
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficient designs for three-sequence stepped wedge trials with continuous recruitment.
    Hooper R; Quintin O; Kasza J
    Clin Trials; 2024 May; ():17407745241251780. PubMed ID: 38773924
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Optimal unidirectional switch designs.
    Zhan Z; de Bock GH; van den Heuvel ER
    Stat Med; 2018 Nov; 37(25):3573-3588. PubMed ID: 30003557
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reconsidering stepped wedge cluster randomized trial designs with implementation periods: Fewer sequences or the parallel-group design with baseline and implementation periods are potentially more efficient.
    Westgate PM; Nigam SR; Shoben AB
    Clin Trials; 2024 Apr; ():17407745241244790. PubMed ID: 38650332
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Designing a stepped wedge trial: three main designs, carry-over effects and randomisation approaches.
    Copas AJ; Lewis JJ; Thompson JA; Davey C; Baio G; Hargreaves JR
    Trials; 2015 Aug; 16():352. PubMed ID: 26279154
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Non-randomized and randomized stepped-wedge designs using an orthogonalized least squares framework.
    Hu Y; Hoover DR
    Stat Methods Med Res; 2018 Apr; 27(4):1202-1218. PubMed ID: 27405326
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Optimal designs using generalized estimating equations in cluster randomized crossover and stepped wedge trials.
    Liu J; Li F
    Stat Methods Med Res; 2024 May; ():9622802241247717. PubMed ID: 38813761
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The batched stepped wedge design: A design robust to delays in cluster recruitment.
    Kasza J; Bowden R; Hooper R; Forbes AB
    Stat Med; 2022 Aug; 41(18):3627-3641. PubMed ID: 35596691
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A hybrid approach to comparing parallel-group and stepped-wedge cluster-randomized trials with a continuous primary outcome when there is uncertainty in the intra-cluster correlation.
    Sarkodie SK; Wason JM; Grayling MJ
    Clin Trials; 2023 Feb; 20(1):59-70. PubMed ID: 36086822
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sample size calculation for stepped-wedge cluster-randomized trials with more than two levels of clustering.
    Teerenstra S; Taljaard M; Haenen A; Huis A; Atsma F; Rodwell L; Hulscher M
    Clin Trials; 2019 Jun; 16(3):225-236. PubMed ID: 31018678
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Five questions to consider before conducting a stepped wedge trial.
    Hargreaves JR; Copas AJ; Beard E; Osrin D; Lewis JJ; Davey C; Thompson JA; Baio G; Fielding KL; Prost A
    Trials; 2015 Aug; 16():350. PubMed ID: 26279013
    [TBL] [Abstract][Full Text] [Related]  

  • 16. swdpwr: A SAS macro and an R package for power calculations in stepped wedge cluster randomized trials.
    Chen J; Zhou X; Li F; Spiegelman D
    Comput Methods Programs Biomed; 2022 Jan; 213():106522. PubMed ID: 34818620
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influential methods reports for group-randomized trials and related designs.
    Murray DM
    Clin Trials; 2022 Aug; 19(4):353-362. PubMed ID: 34991379
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The impact of varying cluster size in cross-sectional stepped-wedge cluster randomised trials.
    Martin JT; Hemming K; Girling A
    BMC Med Res Methodol; 2019 Jun; 19(1):123. PubMed ID: 31200640
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Improving efficiency in the stepped-wedge trial design via Bayesian modeling with an informative prior for the time effects.
    Zhan D; Ouyang Y; Xu L; Wong H
    Clin Trials; 2021 Jun; 18(3):295-302. PubMed ID: 33813906
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A general method for calculating power for GEE analysis of complete and incomplete stepped wedge cluster randomized trials.
    Zhang Y; Preisser JS; Turner EL; Rathouz PJ; Toles M; Li F
    Stat Methods Med Res; 2023 Jan; 32(1):71-87. PubMed ID: 36253078
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.